Money

Okta's Q3 Earnings Anticipated by Wall Street

Wall Street's leading financial experts have revised their projections for Okta Inc. as the company prepares to unveil its third-quarter earnings. The cybersecurity firm is expected to show growth in both revenue and earnings per share, building on its performance from the prior year and surpassing earlier estimates for the second quarter.

Okta's Upcoming Q3 Financial Disclosure Draws Revised Analyst Projections

On Tuesday, December 2nd, following the conclusion of market trading, Okta, Inc., a prominent identity and access management company headquartered in Santa Clara, California, is set to release its financial results for the third fiscal quarter. Market analysts are closely watching, with a consensus expectation for the company to report earnings of 76 cents per share. This figure represents a notable increase from the 67 cents per share recorded during the same period last year. Furthermore, the anticipated revenue for the quarter stands at $730.44 million, a rise from $665 million reported in the corresponding quarter of the previous year, according to financial data from Benzinga Pro.

In related news, Okta had previously surpassed analyst expectations for its second-quarter performance. The company announced revenues of $728 million, exceeding the analysts' forecast of $712.01 million. Following these positive indications, Okta's shares saw a modest appreciation, climbing 0.4% to conclude trading at $80.64 on the preceding Monday.

Several esteemed Wall Street analysts have recently updated their ratings and price targets for Okta. Brian Essex from JP Morgan maintained an 'Overweight' rating but adjusted the price target downwards from $140 to $115 on December 1, 2025. Joseph Gallo of Jefferies upheld a 'Hold' rating, reducing the price target from $105 to $90 on November 25, 2025. Cantor Fitzgerald's Jonathan Ruykhaver reaffirmed an 'Overweight' rating, albeit with a reduced price target from $130 to $115 on November 24, 2025. Saket Kalia from Barclays maintained an 'Equal-Weight' rating, lowering the price target from $112 to $95 on November 18, 2025. Lastly, Mizuho's Gregg Moskowitz kept an 'Outperform' rating but decreased the price target from $120 to $110 on November 17, 2025. These adjustments reflect a dynamic and closely scrutinized investment landscape surrounding Okta.

The proactive revisions by these financial analysts highlight the critical role that upcoming earnings reports play in shaping market sentiment and investment strategies. It underscores the importance for companies like Okta to consistently meet or exceed expectations, as even minor shifts in projections can lead to significant market reactions. For investors, these insights offer valuable perspectives on potential future movements of the stock.

Pre-Market Movements: Health Care Stocks in Focus on Tuesday

This report summarizes the notable movements among health care stocks during Tuesday's pre-market trading. It details companies that experienced significant gains and losses, offering a snapshot of early market dynamics within the health care sector.

Health Sector Sees Volatility in Early Trading

On Tuesday morning, December 2, 2025, the health care sector demonstrated considerable activity in pre-market trading, with several companies experiencing pronounced share price shifts. Among the leading advancers was Mobile-health Network (NASDAQ: MNDR), whose stock surged by 19.4%, reaching a value of $2.21. Following closely was ETHZilla (NASDAQ: ETHZ), which saw its shares appreciate by 17.52% to $11.13. Jasper Therapeutics (NASDAQ: JSPR) also posted a strong performance, with its stock climbing 17.44% to $2.02. Other notable gainers included NRX Pharmaceuticals (NASDAQ: NRXP), increasing by 10.87% to $2.65, Aethlon Medical (NASDAQ: AEMD), up by 9.73% to $4.62, and Fennec Pharmaceuticals (NASDAQ: FENC), which rose by 8.79% to $8.41.

Conversely, some health care stocks faced headwinds during the same pre-market period. Leading the decliners was Janux Therapeutics (NASDAQ: JANX), experiencing a substantial decrease of 38.7% to $20.84 per share. Sensei Biotherapeutics (NASDAQ: SNSE) also saw a significant drop, falling by 12.01% to $7.40. Shares of ProPhase Labs (NASDAQ: PRPH) declined by 10.36% to $0.17, while Citius Oncology (NASDAQ: CTOR) decreased by 8.54% to $1.50. Clearmind Medicine (NASDAQ: CMND) fell by 8.34% to $0.13, and Nexalin Technology (NASDAQ: NXL) recorded a 7.62% reduction, trading at $0.85.

These early market movements underscore the dynamic nature of the health care industry, often influenced by a myriad of factors including regulatory news, clinical trial results, and broader economic trends. Investors closely monitor these shifts to gauge market sentiment and identify potential opportunities or risks.

See More

Key Industrial Stocks Experiencing Significant Movement in Tuesday's Pre-Market Trading

This article provides an overview of industrial sector stocks that exhibited significant price fluctuations during Tuesday's pre-market trading period. It categorizes these companies into those that saw gains and those that experienced declines, offering a concise summary of their performance. The information is designed to inform readers about early market trends in the industrials segment.

Unveiling Early Market Dynamics: Industrial Sector's Movers and Shakers

Companies Showing Positive Momentum in Early Trading

In Tuesday's pre-market session, several industrial stocks registered upward movements. Among these, NN Inc. (NASDAQ: NNBR) saw its shares climb by 7.4%, reaching a price of $1.31. Micropolis Holding Co. (AMEX: MCRP) also experienced a positive trend, with its shares rising by 7.21% to $1.04. BETA Technologies (NYSE: BETA) reported a 5.94% increase, pushing its shares to $27.78. Northann Corp. (AMEX: NCL) recorded a 5.34% gain, bringing its share price to $0.42. Westwater Resources Inc. (AMEX: WWR) observed a 4.97% rise, with shares trading at $0.89. Lastly, Nauticus Robotics Inc. (NASDAQ: KITT) saw its stock advance by 4.81% to $0.79.

Industrial Firms Facing Downward Trends Before Market Open

Conversely, some industrial companies experienced a downturn in their stock values during the same pre-market period. Zenta Group Co. Ltd. (NASDAQ: ZGM) led the declines with a 15.4% drop, settling at $2.41. Intercont (Cayman) Ltd. (NASDAQ: NCT) shares fell by 11.27% to $0.5. GEE Group Inc. (AMEX: JOB) reported a 10.14% decrease, with its shares priced at $0.17. Tianci International Inc. (NASDAQ: CIIT) saw an 8.26% fall, bringing its shares to $0.4. MingZhu Logistics Holdings Ltd. (NASDAQ: YGMZ) stock declined by 7.7% to $0.1. Jayud Global Logistics Ltd. (NASDAQ: JYD) also experienced a decrease, with its shares down 5.96% to $3.95.

See More